Ligand Pharmaceuticals (NASDAQ:LGND) Stock Rating Reaffirmed by Benchmark themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) was the recipient of a large drop in short interest in September. As of September 15th, there was short interest totalling 825,000 shares, a drop of 6.2% from the August 31st total of 879,200 shares. Based on an average daily trading volume, of 94,200 shares, the days-to-cover […]
Stephens Investment Management Group LLC lifted its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by 0.1% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 455,089 shares of the biotechnology company’s stock after acquiring an additional 673 shares during the quarter. Stephens Investment […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) – Analysts at Zacks Research reduced their Q3 2023 EPS estimates for shares of Ligand Pharmaceuticals in a research note issued to investors on Tuesday, August 22nd. Zacks Research analyst S. Ganoria now anticipates that the biotechnology company will earn $0.24 per share for the quarter, down from […]
Ligand Pharmaceuticals (NASDAQ:LGND) Lowered to Hold at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.